packageFostamatinib

fostamatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Fostamatinib, a protein kinase inhibitor, is used to treat thrombocytopenia. It is authorised in the European Union and also has investigational uses.

Summary written by glm-5.3-flash from Wikidata Q5473550 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:fostamatinib
ATC codes:B02BX09
DrugBank:DB12010
PubChem CID:11671467
Wikidata:Q5473550
formula:C23H26FN6O9P
molar mass:580.466 g/mol (PubChem CID 11671467)
logP:1.6 (Drugs.Common 25.09, not verified)

Metabolites

R406R406628.632 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
R406metabolite: R406